MedTrace Logo

Clinical Trials

NCT06090552 | RECRUITING | NA
6000 participants

I CAN DO Surgical ACP

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2025-02-26
Completion:
2028-08-31
Conditions
  • Surgical Advanced Care Planning
Interventions
  • BEHAVIORAL
No Results Yet
NCT06058377 | RECRUITING | PHASE3
3680 participants

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-11-27
Completion:
2032-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT05987241 | RECRUITING | PHASE2/PHASE3
992 participants

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2024-02-02
Completion:
2030-09-02
Conditions
  • Muscle Invasive Bladder Urothelial Carcinoma
  • Muscle Invasive Renal Pelvis Urothelial Carcinoma
  • Muscle Invasive Ureter Urothelial Carcinoma
  • Muscle Invasive Urethral Urothelial Carcinoma
  • Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage IV Bladder Urothelial Carcinoma AJCC v7
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05872737 | COMPLETED | NA
154 participants

FAB Programme for Parents of Children With NDD

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-06-05
Completion:
2025-04-16
Conditions
  • Autism Spectrum Disorder
  • Attention Deficit Hyperactivity Disorder
  • Neurodevelopmental Disorders
  • Intellectual Disability
  • Specific Learning Disorder
  • Communication Disorders
  • Motor Disorders
Interventions
  • BEHAVIORAL
No Results Yet
NCT05858164 | COMPLETED | PHASE1
45 participants

A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-08-07
Completion:
2025-09-26
Conditions
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
NCT05857332 | RECRUITING | PHASE1
60 participants

SG1906 for CLDN18.2-Positive Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-05-30
Completion:
2027-02-28
Conditions
  • Locally Advanced Unresectable or Metastatic Solid Tumors
Interventions
  • DRUG
No Results Yet
NCT05837949 | ACTIVE_NOT_RECRUITING | NA
100 participants

Multiple Sclerosis Falls Insight Track

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-04-12
Completion:
2026-09-01
Conditions
  • Multiple Sclerosis
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page